Trial Profile
Post Marketing Surveillance Study of Sifrol - Monotherapy in Patients With Idiopathic Parkinson's Disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Oct 2014
Price :
$35
*
At a glance
- Drugs Pramipexole (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- Sponsors Boehringer Ingelheim
- 08 Oct 2014 New trial record